PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK; Immunobiology Laboratory, The Francis Crick Institute, London, UK.\', \'Victorian Clinical Genetics Services, The Royal Children\'s Hospital, Melbourne, Australia.\', \'Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.\', \'Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.\', \'Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Mildred Scheel Cancer Career Centre HaTriCs4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'University Hospital Waterford, Waterford, Ireland.\', \'Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.\', \'Department of Dermatology, University Hospital Tübingen, Tübingen, Germany; Portuguese Air Force Health Care Direction, Lisbon, Portugal.\', \'Medical Oncology, Hospital Ramón y Cajal, IRYCIS, Alcalá University, Madrid, Spain.\', \'Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.\', \'Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, Jodhpur, India.\', \'Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany.\', \'Department of Medical and Radiation Oncology, Skåne University Hospital, Lund, Sweden.\', \'Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.\', \'Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK. Electronic address: susana.banerjee@rmh.nhs.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2059-7029(21)00160-510.1016/j.esmoop.2021.100199
?:doi
?:hasPublicationType
?:journal
  • ESMO open
is ?:pmid of
?:pmid
?:pmid
  • 34217129
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34217129>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34217129>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all